These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18288185)

  • 1. The search for new cardiovascular biomarkers.
    Gerszten RE; Wang TJ
    Nature; 2008 Feb; 451(7181):949-52. PubMed ID: 18288185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quest for novel cardiovascular biomarkers by proteomic analysis.
    Vivanco F; Martín-Ventura JL; Duran MC; Barderas MG; Blanco-Colio L; Dardé VM; Mas S; Meilhac O; Michel JB; Tuñón J; Egido J
    J Proteome Res; 2005; 4(4):1181-91. PubMed ID: 16083268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for cardiovascular disease: challenges and future directions.
    May A; Wang TJ
    Trends Mol Med; 2008 Jun; 14(6):261-7. PubMed ID: 18487087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.
    Herder C; Karakas M; Koenig W
    Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for prediction of cardiovascular events.
    Ridker PM; Cook NR
    N Engl J Med; 2007 Apr; 356(14):1472-3; author reply 1474-5. PubMed ID: 17415901
    [No Abstract]   [Full Text] [Related]  

  • 6. Biomarkers for prediction of cardiovascular events.
    Becker DM; Mora S; Goff DC
    N Engl J Med; 2007 Apr; 356(14):1473; author reply 1474-5. PubMed ID: 17415902
    [No Abstract]   [Full Text] [Related]  

  • 7. New cardiovascular risk factors exist, but are they clinically useful?
    Wang TJ
    Eur Heart J; 2008 Feb; 29(4):441-4. PubMed ID: 18276617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.
    Catena C; Cavarape A; Dotto L; Colussi G; Novehllo M; De Marchi S; Sechi LA
    Adv Clin Path; 2003 Jan; 7(1):3-11. PubMed ID: 19774732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying novel biomarkers for cardiovascular disease risk prediction.
    Ge Y; Wang TJ
    J Intern Med; 2012 Nov; 272(5):430-9. PubMed ID: 22950687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New and emerging risk factors for CVD.
    Ferns GA
    Proc Nutr Soc; 2008 May; 67(2):223-31. PubMed ID: 18412996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of risk prediction models in cardiovascular disease research.
    Cui J
    Ann Epidemiol; 2009 Oct; 19(10):711-7. PubMed ID: 19628409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac autonomic neuropathy, estimated cardiovascular risk, and circadian blood pressure pattern in diabetes mellitus.
    Cabezas-Cerrato J; Hermida RC; Cabezas-Agricola JM; Ayala DE
    Chronobiol Int; 2009 Jul; 26(5):942-57. PubMed ID: 19637052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
    Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
    Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of arterial structure and function: towards new biomarkers for aortic stiffness?
    Yasmin ; O'Shaughnessy KM
    Clin Sci (Lond); 2008 Jun; 114(11):661-77. PubMed ID: 18442360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What are the biomarkers of atherosclerosis and cardiovascular risk?].
    Riesen WF
    Rev Med Suisse; 2008 Mar; 4(148):636-8, 640-3. PubMed ID: 18459658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing cardiovascular disease in Kentucky: epidemiology, trends, and strategies for the future.
    Rugg SS; Bailey AL; Browning SR
    J Ky Med Assoc; 2008 Apr; 106(4):149-61; quiz 149, 162-3. PubMed ID: 18478845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and emerging biomarkers of heart failure.
    Clerico A; Vittorini S; Passino C; Emdin M
    Crit Rev Clin Lab Sci; 2009; 46(3):107-28. PubMed ID: 19514904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers for cardiovascular disease: cardiovascular biomarkers to proteomic discovery.
    Suzuki T; Nagai R
    Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):295. PubMed ID: 18506210
    [No Abstract]   [Full Text] [Related]  

  • 20. The first SHAPE (Screening for Heart Attack Prevention and Education) guideline.
    Naghavi M; Falk E; Hecht HS; Shah PK;
    Crit Pathw Cardiol; 2006 Dec; 5(4):187-90. PubMed ID: 18340236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.